[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342967-105":59,"doc-detail-342967-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","metabolomic-profiling-of-upper-gi-malignancies-in-blood-and-tissue-a-systematic-review-and-meta-analysis","Metabolomic profiling of upper GI malignancies in blood and tissue - a systematic review and meta-analysis","","Systematic review and meta-analysis evaluate case–control and cohort human studies assessing metabolite markers discovered via high-throughput metabolomics for esophageal cancer, gastroesophageal junction cancer, and gastric cancer, using both blood and tissue samples. Searches followed PRISMA across four databases, with study quality assessed using Newcastle–Ottawa Scale and diagnostic accuracy rated via QUADOMICS. Sixty-six studies including 7267 patients were synthesized using random-effects models to relate metabolite levels with disease presence.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/metabolomic-profiling-of-upper-gi-malignancies-in-blood-and-tissue-a-systematic-review-and-meta-analysis/342967/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/metabolomic-profiling-of-upper-gi-malignancies-in-blood-and-tissue-a-systematic-review-and-meta-analysis/342967.png","ImageObject",300,407,{"name":92,"@type":93},"Noah","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the objective of this systematic review and meta-analysis?","Question",{"text":112,"@type":113},"To summarize evidence on metabolite markers for esophageal cancer, cancer of the gastroesophageal junction, and gastric cancer identified using high-throughput metabolomics in blood and tissue.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were studies identified and assessed for quality?",{"text":117,"@type":113},"Following PRISMA, four databases were searched and PROSPERO registration was used. Risk of bias was benchmarked with the Newcastle–Ottawa Scale, and diagnostic accuracy studies were rated using an adaptation of QUADAS-2 called QUADOMICS.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the main findings regarding metabolites in patients with upper GI cancers?",{"text":121,"@type":113},"Across 66 studies (7267 patients), 169 metabolites differed between upper GI malignancy patients and healthy patients, with glycolysis, anaerobic respiration, TCA cycle, and lipid metabolism pathways frequently represented.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},342967,1790402611,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","Journal of Cancer Research and Clinical Oncology (2024) 150:331  \n[https://doi.org/10.1007/s00432-024-05857-5](https://doi.org/10.1007/s00432-024-05857-5)  \nMetabolomic profiling of upper GI malignancies in blood and tissue: a systematic review and meta‑analysis  \nIlja Balonov1 · Minca Mattis1 · Stefanie Jarmusch1 · Berthold Koletzko2 · Kathrin Heinrich3 · Jens Neumann4 · Jens Werner1 · Martin K. Angele1 · Christian Heiliger1 · Sven Jacob1  \nReceived: 10 May 2024 / Accepted: 17 June 2024 / Published online: 1 July 2024 © The Author(s) 2024  \nAbstract  \nObjective To conduct a systematic review and meta-analysis of case–control and cohort human studies evaluating metabolite markers identified using high-throughput metabolomics techniques on esophageal cancer (EC), cancer of the gastroesophageal junction (GEJ), and gastric cancer (GC) in blood and tissue.  \nBackground Upper gastrointestinal cancers (UGC), predominantly EC, GEJ, and GC, are malignant tumour types with high morbidity and mortality rates. Numerous studies have focused on metabolomic profiling of UGC in recent years. In this systematic review and meta-analysis, we have provided a collective summary of previous findings on metabolites and metabolomic profiling associated with EC, GEJ and GC.  \nMethods Following the PRISMA procedure, a systematic search of four databases (Embase, PubMed, MEDLINE, and Web of Science) for molecular epidemiologic studies on the metabolomic profiles of EC, GEJ and GC was conducted and registered at PROSPERO (CRD42023486631). The Newcastle–Ottawa Scale (NOS) was used to benchmark the risk of bias for case-controlled and cohort studies. QUADOMICS, an adaptation of the QUADAS-2 (Quality Assessment of Diagnostic Accuracy) tool, was used to rate diagnostic accuracy studies. Original articles comparing metabolite patterns between patients with and without UGC were included. Two investigators independently completed title and abstract screening, data extraction, and quality evaluation. Meta-analysis was conducted whenever possible. We used a random effects model to investigate the association between metabolite levels and UGC.  \nResults A total of 66 original studies involving 7267 patients that met the required criteria were included for review. 169 metabolites were differentially distributed in patients with UGC compared to healthy patients among 44 GC, 9 GEJ, and 25 EC studies including metabolites involved in glycolysis, anaerobic respiration, tricarboxylic acid cycle, and lipid metabolism. Phosphatidylcholines, eicosanoids, and adenosine triphosphate were among the most frequently reported lipids and metabolites of cellular respiration, while BCAA, lysine, and asparagine were among the most commonly reported amino acids. Previously identified lipid metabolites included saturated and unsaturated free fatty acids and ketones. However, the key findings across studies have been inconsistent, possibly due to limited sample sizes and the majority being hospital-based case–control analyses lacking an independent replication group.  \nConclusion Thus far, metabolomic studies have provided new opportunities for screening, etiological factors, and biomarkers for UGC, supporting the potential of applying metabolomic profiling in early cancer diagnosis. According to the results of our meta-analysis especially BCAA and TMAO as well as certain phosphatidylcholines should be implicated into the diagnostic procedure of patients with UGC. We envision that metabolomics will significantly enhance our understanding of the carcinogenesis and progression process of UGC and may eventually facilitate precise oncological and patient-tailored management of UGC.  \nKeywords Gastric cancer · Esophageal cancer · Cancer of the gastroesophageal junction · Tumour microenvironment · Metabolomics · Metabolomic profile · Oncometabolomic · Mass spectrometry · Meta-analysis  \nChristian Heiliger and Sven Jacob have contributed equally to this study.  \nExtended author information a","cbCaioBdW4cASljd","https://ap.wps.com/l/cbCaioBdW4cASljd","pdf",2222223,26,"English","## Objective\n## Background\n## Methods\n## Results\n## Conclusion\n## Keywords","[{\"question\":\"What is the objective of this systematic review and meta-analysis?\",\"answer\":\"To summarize evidence on metabolite markers for esophageal cancer, cancer of the gastroesophageal junction, and gastric cancer identified using high-throughput metabolomics in blood and tissue.\"},{\"question\":\"How were studies identified and assessed for quality?\",\"answer\":\"Following PRISMA, four databases were searched and PROSPERO registration was used. Risk of bias was benchmarked with the Newcastle–Ottawa Scale, and diagnostic accuracy studies were rated using an adaptation of QUADAS-2 called QUADOMICS.\"},{\"question\":\"What were the main findings regarding metabolites in patients with upper GI cancers?\",\"answer\":\"Across 66 studies (7267 patients), 169 metabolites differed between upper GI malignancy patients and healthy patients, with glycolysis, anaerobic respiration, TCA cycle, and lipid metabolism pathways frequently represented.\"}]","Metabolomic profiling of upper GI malignancies in blood and tissue - a systematic review and meta-analysis | PDF",1790049170,66,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/128d9808a31c5d7cbf953244eb331ea8.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/204381d0eff75f2e349a658ec86099d6.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f94a97e90f123802da890da8833fb37c.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/786a4f4ae3e7493a6797cb16215cb4f7.webp",980,1301]